INSR and cancer: In particular, it is now well accepted that IR and its homolog IGF-1R are functionally interconnected by forming hybrid receptors with an important role in cancer (321), and that targeting either IR or IGF-1R alone results in increased activity of the homolog receptor (322) and resistance to treatment.